Unifiedpost Group rebrands to Banqup Group, reinforcing its position as a pure-play SaaS provider
Unifiedpost Group rebrands to Banqup Group, reinforcing its position as a pure-play SaaS provider
La Hulpe, Belgium – 20 May 2025, 22:00 CET – REGULATED INFORMATION – Banqup Group SA, formerly Unifiedpost Group SA, (Euronext: UPG) (Banqup, Company), a leading provider of integrated business communications solutions, held an Extraordinary General Meeting (EGM) and Annual General Meeting (AGM).
The shareholders approved all proposed resolutions (here), including:
EGM: Strategic rebranding from Unifiedpost Group SA to Banqup Group SA across the Group. This further underpins our focus on core digital services and aligns our business as a pure-play SaaS provider. The rebranding offers our stakeholders a clear understanding of our product and value proposition, reinforcing our commitment to growth in e-invoicing and payment solutions.
AGM: Enhanced governance with the approval of the updated remuneration policy and the appointment of four new Board members:
Nicolas de Beco, representing Beco Global Consulting LLC, as executive director
Nathalie Van Den Haute, representing Quilaudem BV, as non-executive director
Koen Hoffman, representing Ahok BV, as an independent director
Leanne Kemp as an independent director
The minutes, voting results and presentation of the AGM will be available on the shareholder page (here) in the coming days.
Financial Calendar:
22 May 2025: Publication of the Q1 2025 business update
26 August 2025: Publication of the H1 2025 results (webcast)
13 November 2025: Publication of the Q3 2025 business update
ContactAlex NicollInvestor RelationsBanqup Groupalex.nicoll@unifiedpost.com
About Banqup Group
Banqup Group delivers integrated cloud-based SaaS solutions to streamline business transactions across the entire lifecycle, from e-invoicing and e-payments to tax reporting. Banqup, our solution for businesses, unifies purchase-to-pay, order-to-cash, e-invoicing compliance, and e-payments into one secure platform, removing the complexity of juggling disconnected tools. eFaktura World, our solution for governments, is a comprehensive digital platform designed for tax administrations to implement e-invoicing and streamline both B2G and B2B tax reporting flows. To learn more about Banqup Group and our solutions, please visit our website: Unifiedpost Group | Global leaders in digital solutions
Cautionary note regarding forward-looking statements: The statements contained herein may include prospects, statements of future expectations, opinions, and other forward-looking statements in relation to the expected future performance of Banqup Group and the markets in which it is active. Such forward-looking statements are based on management's current views and assumptions regarding future events. By nature, they involve known and unknown risks, uncertainties, and other factors that appear justified at the time at which they are made but may not turn out to be accurate. Actual results, performance or events may, therefore, differ materially from those expressed or implied in such forward-looking statements. Except as required by applicable law, Banqup Group does not undertake any obligation to update, clarify or correct any forward-looking statements contained in this press release in light of new information, future events or otherwise and disclaims any liability in respect hereto. The reader is cautioned not to place undue reliance on forward-looking statements.
Attachment
Press release
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
3 days ago
- Business Upturn
CMB.TECH Business update Q2 2025 results
Antwerp, Aug. 14, 2025 (GLOBE NEWSWIRE) — NV (NYSE: CMBT & Euronext: CMBT) ('CMBT', ' or 'the Company') will release its second quarter 2025 earnings prior to market opening on Thursday 28 August 2025 and will host a conference call at 8 a.m. EST / 2 p.m. CET to discuss the results for the quarter. Due to the proximity of the expected closing date of the contemplated stock-for-stock merger between and Golden Ocean Group Limited ('Golden Ocean'), already provides preliminary figures related to the Q2 2025 results in this business update. Business update Q2 2025 results are scheduled to be announced by on 28 August 2025. Due to the proximity of the expected closing date of the contemplated stock-for-stock merger between and Golden Ocean, provides the following selected, preliminary figures related to Q2 2025 results: Key figures The most important preliminary key figures (unaudited) are: to be found in attachment. provides this information based on the current status of completing its Q2 2025 results and report. has not completed all its financial reporting and related consolidation, review and control procedures. The estimates provided are therefore subject to finalisation and change. Consequently, the finalised and approved Q2 2025 results, to be published by on 28 August 2025, may deviate from the above information. Details Q2 2025 earnings conference call on 28 August 2025 The call will be a webcast with an accompanying slideshow. You can find the details of this conference call below and on the 'Investor Relations' page of the website. The presentation, recording & transcript will also be available on this page. Webcast Information Event Type: Audio webcast with user-controlled slide presentation Event Date: 28 August 2025 Event Time: 8 a.m. EST / 2 p.m. CET Event Title: 'Q2 2025 Earnings Conference Call' Event Site/URL: To attend this conference call, please register via the following link. Telephone participants who are unable to pre-register may dial in to the respective number of their location (to be found here). The Phone conference ID is the following: 354 264 600# Announcement Q2 2025 results – 28 August 2025 About (all capitals) is a diversified and future-proof maritime group. We own and operate more than 150 seagoing vessels: crude oil tankers, dry bulk vessels, container ships, chemical tankers, offshore wind vessels & workboats. We also offer hydrogen and ammonia fuel to customers, through own production or third-party producers. The company is headquartered in Antwerp, Belgium, and has offices across Europe, Asia, United States and Africa. is listed on Euronext Brussels and the NYSE under the ticker symbol CMBT. More information can be found at Forward-Looking Statements Matters discussed in this press release may constitute forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides safe harbour protections for forward-looking statements in order to encourage companies to provide prospective information about their business. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are other than statements of historical facts. The Company desires to take advantage of the safe harbour provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary statement in connection with this safe harbour legislation. The words 'believe', 'anticipate', 'intends', 'estimate', 'forecast', 'project', 'plan', 'potential', 'may', 'should', 'expect', 'pending' and similar expressions identify forward-looking statements. The forward-looking statements in this press release are based upon various assumptions, many of which are based, in turn, upon further assumptions, including without limitation, our management's examination of historical operating trends, data contained in our records and other data available from third parties. Although we believe that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies which are difficult or impossible to predict and are beyond our control, we cannot assure you that we will achieve or accomplish these expectations, beliefs or projections. In addition to these important factors, other important factors that, in our view, could cause actual results to differ materially from those discussed in the forward-looking statements include the failure of counterparties to fully perform their contracts with us, the strength of world economies and currencies, general market conditions, including fluctuations in charter rates and vessel values, changes in demand for tanker vessel capacity, changes in our operating expenses, including bunker prices, dry-docking and insurance costs, the market for our vessels, availability of financing and refinancing, charter counterparty performance, ability to obtain financing and comply with covenants in such financing arrangements, changes in governmental rules and regulations or actions taken by regulatory authorities, potential liability from pending or future litigation, general domestic and international political conditions, potential disruption of shipping routes due to accidents or political events, vessels breakdowns and instances of off-hires and other factors. Please see our filings with the United States Securities and Exchange Commission for a more complete discussion of these and other risks and uncertainties. Attachment Business update Q2 2025 results Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
Yahoo
3 days ago
- Yahoo
Marimekko's financial reporting and Annual General Meeting in 2026
Marimekko Corporation, Stock Exchange Release, 14 August 2025 at 8.15 a.m. EEST Marimekko's financial reporting and Annual General Meeting in 2026 In 2026, Marimekko Corporation will publish financial information as follows: Financial Statements Bulletin 2025 on Thursday 12 February 2026 at 8.00 a.m. Interim Report 1 January–31 March 2026 on Wednesday 13 May 2026 at 8.00 a.m. Half-year Financial Report 1 January–30 June 2026 on Thursday 13 August 2026 at 8.00 a.m. Interim Report 1 January–30 September 2026 on Wednesday 4 November 2026 at 8.00 a.m. Marimekko observes a silent period of 30 days prior to publishing of financial information. The company's Financial Statements and the Report of the Board of Directors 2025 will be published on the company's website in week 13, at the latest. Marimekko's Annual General Meeting is planned to be held on Thursday 16 April 2026 at 2 p.m. The notice to convene the Annual General Meeting will be given later by the Board of Directors. A shareholder may request that a matter falling within the competence of the General Meeting shall be placed on the agenda of the Annual General Meeting. To this effect, a written request should be sent to the Board of Directors on Thursday 15 January 2026, at the latest. An announcement on the resolutions of the Annual General Meeting will be released after the meeting. MARIMEKKO CORPORATIONCorporate Communications Anna TuominenTel. +358 40 DISTRIBUTION:Nasdaq Helsinki LtdKey media Marimekko is a Finnish lifestyle design company renowned for its original prints and colors. The company's product portfolio includes high-quality clothing, bags and accessories as well as home décor items ranging from textiles to tableware. When Marimekko was founded in 1951, its unparalleled printed fabrics gave it a strong and unique identity. In 2024, the company's net sales totaled EUR 183 million and comparable operating profit margin was 17.5 percent. Globally, there are roughly 170 Marimekko stores, and online store serves customers in 39 countries. The key markets are Northern Europe, the Asia-Pacific region and North America. The Group employs about 480 people. The company's share is quoted on Nasdaq Helsinki Ltd.
Business Wire
4 days ago
- Business Wire
Celyad Oncology SA: Publication of a Transparency Notification Received from Fortress Investment Group LLC
MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--Regulatory News: Celyad Oncology SA (Euronext: CYAD) ('Celyad Oncology' or the 'Company') today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the 'Transparency Law'), that it received a notification of transparency dated August 11, 2025, indicating that CFIP CLYD (UK) Limited, an affiliate of Fortress Investment Group LLC, has crossed the statutory threshold of 60%, holding 32,691,987 voting rights, i.e. 60.96% of Celyad Oncology's voting rights. Content of the Notification: Reason of the Notification: Acquisition or disposal of voting securities or voting rights Notification by: A parent undertaking or a controlling person Persons subject to the notification requirement: Fortress Investment Group LLC - 1345 Avenue of the Americas, New York, NY 10105 United States CFIP CLYD (UK) Limited - 7 Clarges Street, 4th Floor, London W1J 8AE, United Kingdom Date on which the threshold is crossed: August 5, 2025 Threshold that is crossed (in %): 60 Denominator: 53,630,280 Notified details: Full chain of controlled undertakings through which the holdings is effectively held: CFIP CLYD (UK) Limited ('CFIP UK'), a UK limited liability company directly holds 32,691,987 voting rights in the issuer. CFIP CLYD LLC, a Delaware limited liability company ('CFIP'), is the parent of CFIP UK. FIP II UB Investments LP, a Delaware limited partnership ('FIP II'), holds 50% of the membership interests in CFIP. FIP Fund II GP LLC, a Delaware limited liability company ('FIP II GP'), is the general partner of FIP II. Hybrid GP Holdings LLC, a Delaware limited liability company ('Hybrid GP'), is the parent of FIP II GP and indirectly controls the general partners of certain investment funds that hold membership interests in CFIP. FIG LLC, a Delaware limited liability company ('FIG LLC'), is an investment advisor registered with the US Securities and Exchange Commission and indirectly controls the investment advisers to certain investment funds that hold membership interests in CFIP. Fortress Operating Entity I LP, a Delaware limited partnership ('FOE I'), is (i) the sole owner of FIG LLC and (ii) the managing member of, and holds the majority of equity interest in, Hybrid GP. FIG Blue LLC (formerly known as FIG Corp.), a Delaware limited liability company ('FIG Blue') is the general partner of FOE I. Fortress Investment Group LLC, a Delaware limited liability company ('Fortress') is the sole owner of FIG Blue. Fortress, acting through the investment advisers owned and controlled by FIG LLC, holds discretionary authority over the funds that indirectly hold the membership interests in CFIP, and can exercise the voting rights associated therewith without any instruction from its clients Additional information: This transparency notification covers the crossing of the 60% threshold due to a capital increase on 5 August 2025 whereby CFIP CLYD (UK) Limited received 3,333,333 additional shares of Celyad Oncology. As a result, CFIP CLYD (UK) currently holds 32,691,987 voting rights. Miscellaneous The Press Release may be consulted on the website of Celyad Oncology: The notification can be consulted on the website of Celyad Oncology: About Celyad Oncology Celyad Oncology is a cutting-edge biotechnology company focused primarily on unlocking the potential of its proprietary CAR-T technology platforms and intellectual property. The Company is headquartered in Mont Saint-Guibert, Belgium. For more information, visit Forward-looking statements This release may contain forward-looking statements, including, without limitation, statements regarding beliefs about and expectations for the Company's updated strategic business model, including associated potential benefits, transactions and partnerships, statements regarding the potential value of the Company's IP, statements regarding the Company's financial statements and cash runway, statements regarding the Company's future fundraising plans, statements regarding the Company's hiring plans, and statements regarding the continuation of the Company's existence. The words 'will,' 'potential,' 'continue,' 'target,' 'project,' 'should' and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements in this release are based on management's current expectations and beliefs and are subject to a number of known and unknown risks, uncertainties and important factors which might cause actual events, results, financial condition, performance or achievements of Celyad Oncology to differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks related to the material uncertainty about the Company's ability to continue as a going concern; the Company's ability to realize the expected benefits of its updated strategic business model; the Company's ability to develop its IP assets and enter into partnerships with outside parties; the Company's ability to enforce its patents and other IP rights; the possibility that the Company may infringe on the patents or IP rights of others and be required to defend against patent or other IP rights suits; the possibility that the Company may not successfully defend itself against claims of patent infringement or other IP rights suits, which could result in substantial claims for damages against the Company; the possibility that the Company may become involved in lawsuits to protect or enforce its patents, which could be expensive, time-consuming, and unsuccessful; the Company's ability to protect its IP rights throughout the world; the potential for patents held by the Company to be found invalid or unenforceable; and other risks identified in the latest Annual Report of Celyad Oncology. These forward-looking statements speak only as of the date of publication of this document and Celyad Oncology's actual results may differ materially from those expressed or implied by these forward-looking statements. Celyad Oncology expressly disclaims any obligation to update any such forward-looking statements in this document to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based, unless required by law or regulation.
